May 16, 2000
Collaboration leads to advancement in MS research
May is designated as Multiple Sclerosis month – a time to create awareness about this debilitating disease that affects nearly 50,000 Canadians. Canada has one of the highest rates of Multiple Sclerosis (MS) in the world, and it is the most common disease of the central nervous system affecting young adults in this country. Collaboration between basic science researchers at The Hospital for Sick Children (SickKids), through funding from the Multiple Sclerosis Society of Canada, and clinicians at St. Michael’s Hospital, has led to promising clinical trials to treat MS.
WHAT: News conference to discuss exciting clinical trial results and the creation of North America’s first paediatric MS clinic
WHEN: Wednesday, May 17, 11:30 a.m.
WHERE: The Hospital for Sick Children
555 University Avenue, Toronto
The Rotunda, 1st Floor Black Family Wing (just inside main University Avenue entrance)
SPEAKERS: Dr. Brenda Banwell, neurologist and head of SickKids MS Clinic
Dr. Mario Moscarello, senior scientist emeritus, SickKids Research Institute
Dr. Paul O’Connor, chief, Division of Neurology, and director MS Clinic and MS Research, St. Michael’s Hospital
Deanna Groetzinger, vice-president, communications, Multiple Sclerosis Society of Canada
Michelle Ameri, MS patient
For more information, please contact:
Public Affairs
The Hospital for Sick Children
555 University Avenue
Suite 1742, Public Affairs, First floor Atrium
Toronto,
ON
M5G 1X8
Canada
Phone: 416-813-5058
Fax: 416-813-5328